Table 1 Baseline characteristics of enrolled patients
Characteristics | Total | PCCs (82) | PBMNCs (78) | P |
|---|---|---|---|---|
Age, years | 41.2 (11.2) | 40.6 (10.5) | 41.8 (11.8) | .610 |
Male, n (%) | 157 (98.1) | 80 (97.6) | 77 (96.3) | .990 |
BMI, kg/m2 | 23.2 (3.7) | 23.5 (3.5) | 22.9 (3.8) | .820 |
Etiology | ||||
 TAO, n (%) | 155 (96.9) | 79 (96.3) | 76 (97.4) | 1.000 |
 Eosinophilia, n (%) | 1 (0.63) | 0 (0) | 1 (1.30) | .487 |
 SLE, n (%) | 3 (1.88) | 2 (2.4) | 1 (1.3) | 1.000 |
 Erythema nodosum, n (%) | 1 (0.63) | 1 (1.2) | 0 (0) | 1.000 |
Comorbidities | ||||
 Smoking, n (%) | 145 (90.6) | 72 (87.8) | 73 (93.6) | .210 |
 Hypertension, n (%) | 8 (5.0) | 5 (6.1) | 3 (3.8) | .720 |
 Type II diabetes mellitus, n (%) | 8 (5.0) | 4 (4.9) | 4 (5.1) | .990 |
 Hyperlipidemia, n (%) | 11 (6.88) | 7 (8.5) | 4 (5.1) | .394 |
 Coronary artery disease, n (%) | 3 (1.88) | 2 (2.4) | 1 (1.3) | .990 |
Treated limbs | ||||
 Upper/lower extremity, n | 5/155 | 3/79 | 2/76 | .990 |
 Right/left, n | 86/74 | 44/38 | 42/36 | .989 |
 Ulcer only, n (%) | 75 (46.9) | 34 (41.5) | 41 (52.6) | .160 |
 Gangrene, n (%) | 70 (43.8) | 37 (4.1) | 33 (42.3) | .720 |
Rutherford class | ||||
 4, n (%) | 15 (18.3) | 11 (13.4) | 4 (5.1) | .720 |
 5, n (%) | 145 (90.6) | 71 (86.6) | 74 (94.9) | .720 |
Medication history | ||||
 Aspirin, n (%) | 134 (83.8) | 66 (80.5) | 68 (87.2) | .251 |
 Clopidogrel, n (%) | 18 (11.3) | 10 (12.2) | 8 (11.2) | .698 |
 Cilostazol, n (%) | 61 (38.1) | 32 (39.0) | 29 (37.2) | .810 |
 Prostaglandins, n (%) | 124 (77.5) | 61 (74.4) | 63 (80.8) | .334 |
 Warfarin, n (%) | 6 (3.8) | 4 (4.9) | 2 (2.6) | .682 |
 Rivaroxaban, n (%) | 5 (3.1) | 2 (2.4) | 3 (3.8) | .676 |
Surgical history | ||||
 Bypass, n (%) | 18 (11.3) | 11 (13.4) | 7 (9.0) | .374 |
 Endarterectomy, n (%) | 5 (3.1) | 3 (3.7) | 2 (2.6) | 1.000 |
 PTA, n (%) | 42 (26.3) | 20 (24.2) | 22 (28.2) | .584 |
 Stenting, n (%) | 16 (10.0) | 8 (9.8) | 8 (10.3) | .916 |
 Thrombolysis, n (%) | 52 (32.5) | 28 (34.1) | 24 (30.8) | .648 |
 Sympathectomy, n (%) | 7 (4.4) | 2 (2.4) | 5 (6.4) | .268 |
 Surgical thrombectomy, n (%) | 22 (13.8) | 12 (14.6) | 10 (12.8) | .739 |
 Excimer laser thrombectomy, n (%) | 7 (4.4) | 2 (2.4) | 5 (6.4) | .268 |